These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 1354642)
21. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546 [TBL] [Abstract][Full Text] [Related]
22. [In vitro contracture test and gene typing in diagnosing malignant hyperthermia. Each as an appropriate complement to the other method]. Rüffert H; Olthoff D; Deutrich C; Thamm B; Froster U Anaesthesist; 2000 Feb; 49(2):113-20. PubMed ID: 10756965 [TBL] [Abstract][Full Text] [Related]
23. North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations. Sambuughin N; Sei Y; Gallagher KL; Wyre HW; Madsen D; Nelson TE; Fletcher JE; Rosenberg H; Muldoon SM Anesthesiology; 2001 Sep; 95(3):594-9. PubMed ID: 11575529 [TBL] [Abstract][Full Text] [Related]
24. The G1021A substitution in the RYR1 gene does not cosegregate with malignant hyperthermia susceptibility in a British pedigree. Adeokun AM; West SP; Ellis FR; Halsall PJ; Hopkins PM; Foroughmand AM; Iles DE; Robinson RL; Stewart AD; Curran JL Am J Hum Genet; 1997 Apr; 60(4):833-41. PubMed ID: 9106529 [TBL] [Abstract][Full Text] [Related]
25. Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia. O'Brien RO; Taske NL; Hansbro PM; Matthaei KI; Hogan SP; Denborough MA; Foster PS J Med Genet; 1995 Nov; 32(11):913-4. PubMed ID: 8592342 [TBL] [Abstract][Full Text] [Related]
26. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Fujii J; Otsu K; Zorzato F; de Leon S; Khanna VK; Weiler JE; O'Brien PJ; MacLennan DH Science; 1991 Jul; 253(5018):448-51. PubMed ID: 1862346 [TBL] [Abstract][Full Text] [Related]
27. Genomic organization and analysis of the 5' end of the porcine ryanodine receptor gene (ryr1). Brenig B; Brem G FEBS Lett; 1992 Feb; 298(2-3):277-9. PubMed ID: 1312025 [TBL] [Abstract][Full Text] [Related]
29. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Quane KA; Healy JM; Keating KE; Manning BM; Couch FJ; Palmucci LM; Doriguzzi C; Fagerlund TH; Berg K; Ording H Nat Genet; 1993 Sep; 5(1):51-5. PubMed ID: 8220423 [TBL] [Abstract][Full Text] [Related]
30. Genetic analysis with calcium-induced calcium release test in Japanese malignant hyperthermia susceptible (MHS) families. Maehara Y; Mukaida K; Hiyama E; Morio M; Kawamoto M; Yuge O Hiroshima J Med Sci; 1999 Mar; 48(1):9-15. PubMed ID: 10213958 [TBL] [Abstract][Full Text] [Related]
31. The genetic basis of malignant hyperthermia. Moochhala SM; Tan WT; Lee TL Ann Acad Med Singap; 1994 Jul; 23(4):475-8. PubMed ID: 7979121 [TBL] [Abstract][Full Text] [Related]
32. A mutation in the human ryanodine receptor gene associated with central core disease. Zhang Y; Chen HS; Khanna VK; De Leon S; Phillips MS; Schappert K; Britt BA; Browell AK; MacLennan DH Nat Genet; 1993 Sep; 5(1):46-50. PubMed ID: 8220422 [TBL] [Abstract][Full Text] [Related]
33. Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Iles DE; Lehmann-Horn F; Scherer SW; Tsui LC; Olde Weghuis D; Suijkerbuijk RF; Heytens L; Mikala G; Schwartz A; Ellis FR Hum Mol Genet; 1994 Jun; 3(6):969-75. PubMed ID: 7951247 [TBL] [Abstract][Full Text] [Related]
34. Co-segregation of the malignant hyperthermia and the Arg615-Cys615 mutation in the skeletal muscle calcium release channel protein in five European Landrace and Pietrain pig breeds. Vögeli P; Bolt R; Fries R; Stranzinger G Anim Genet; 1994 Jun; 25 Suppl 1():59-66. PubMed ID: 7943985 [TBL] [Abstract][Full Text] [Related]
35. Analysis of the entire ryanodine receptor type 1 and alpha 1 subunit of the dihydropyridine receptor (CACNA1S) coding regions for variants associated with malignant hyperthermia in Australian families. Gillies RL; Bjorksten AR; Du Sart D; Hockey BM Anaesth Intensive Care; 2015 Mar; 43(2):157-66. PubMed ID: 25735680 [TBL] [Abstract][Full Text] [Related]
36. Novel skeletal muscle ryanodine receptor mutation in a large Brazilian family with malignant hyperthermia. McWilliams S; Nelson T; Sudo RT; Zapata-Sudo G; Batti M; Sambuughin N Clin Genet; 2002 Jul; 62(1):80-3. PubMed ID: 12123492 [TBL] [Abstract][Full Text] [Related]
37. [Molecular genetic analysis of the ryanodine receptor gene (RYR1) in Korean malignant hyperthermia families]. Lee H; Kim DC; Lee JH; Cho YG; Lee HS; Choi SI; Kim DS Korean J Lab Med; 2010 Dec; 30(6):702-10. PubMed ID: 21157159 [TBL] [Abstract][Full Text] [Related]
38. Refinement of diagnostic assays for a probable causal mutation for porcine and human malignant hyperthermia. Otsu K; Phillips MS; Khanna VK; de Leon S; MacLennan DH Genomics; 1992 Jul; 13(3):835-7. PubMed ID: 1639409 [TBL] [Abstract][Full Text] [Related]
39. Mutation screening of the RYR1-cDNA from peripheral B-lymphocytes in 15 Swedish malignant hyperthermia index cases. Broman M; Gehrig A; Islander G; Bodelsson M; Ranklev-Twetman E; Rüffert H; Müller CR Br J Anaesth; 2009 May; 102(5):642-9. PubMed ID: 19346234 [TBL] [Abstract][Full Text] [Related]
40. Cosegregation of porcine malignant hyperthermia and a probable causal mutation in the skeletal muscle ryanodine receptor gene in backcross families. Otsu K; Khanna VK; Archibald AL; MacLennan DH Genomics; 1991 Nov; 11(3):744-50. PubMed ID: 1774073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]